AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 7 added, 4 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- 1 awardAwards on record
Key stats
Fundamentals Sep 30- Open
- $319.28
- 52-wk high
- $362.41
- High
- $319.61
- 52-wk low
- $221.26
- Low
- $318.17
- Prev close
- $319.72
- Mkt cap
- $12.57B
- P/E
- 78.0x
- Volume
- 228.1K
- Fwd P/E
- 55.6x
- Beta
- 0.70
- P/S
- 8.3x
- P/B
- 8.2x
- Profit margin
- +10.7%
- Op margin
- +10.5%
- ROE
- +11.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about PEN filings
Are insiders buying or selling Penumbra Inc (PEN) stock?
Neither. Penumbra Inc (PEN) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded PEN recently?
None. No member of Congress disclosed a PEN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this PEN smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- EP
ExodusPoint
$191.5M
added
- TS
Two Sigma
$116.1M
added
- CI
Citadel
$75.1M
added
What insiders are doing
Sells (1)
- GH
Grewal Harpreet
$33K
sold
How top traders are positioned
No tracked top-trader positions in PEN right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 7.4% below what analysts expected.
Earnings per share
$1.09 expected
Reports Nov 4, 2026, in 34 days
Estimates as of Sep 30, 2026
EPS expected
$1.07 to $1.29
Revenue expected
7 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $354.7M | $385.4M | $374.8M | $390.0M |
| Cost of what it sold | $114.3M | $123.3M | $121.3M | $125.1M |
| Gross profit | $240.4M | $262.1M | $253.4M | $264.9M |
| What it spent | ||||
| Research and development | $22.7M | $21.8M | $22.4M | $25.4M |
| Sales and admin | $168.9M | $181.1M | $192.8M | $198.5M |
| Total operating expenses | $191.6M | $202.9M | $215.2M | $223.9M |
| What was left | ||||
| Operating profit | $48.8M | $59.2M | $38.2M | $41.0M |
| Interest on debt | $338.0K | $333.0K | $317.0K | $311.0K |
| Profit before tax | $52.3M | $63.6M | $41.7M | $46.2M |
| Tax | $6.5M | $16.3M | $9.1M | $11.4M |
| Net profit | $45.9M | $47.3M | $32.6M | $34.8M |
| EBITDA | $55.2M | $68.4M | $46.6M | $52.1M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace